Transient cytokine-induced liver injury following administration of the humanized anti-CD3 antibody visilizumab (HuM291) in Crohn's disease (Q33412103)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Transient cytokine-induced liver injury following administration of the humanized anti-CD3 antibody visilizumab (HuM291) in Crohn's disease
scientific article

    Statements

    Transient cytokine-induced liver injury following administration of the humanized anti-CD3 antibody visilizumab (HuM291) in Crohn's disease (English)
    Daniel C Baumgart
    James N Lowder
    Matthew B Frankel
    24 February 2009

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit